financetom
Business
financetom
/
Business
/
Sharp hike in ferrochrome prices boosted Q1 performance, expect Q2 EBITDA around Rs 250 crore: IMFA
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Sharp hike in ferrochrome prices boosted Q1 performance, expect Q2 EBITDA around Rs 250 crore: IMFA
Jul 26, 2021 9:54 AM

Indian Metals & Ferro Alloys or IMFA stock surged in trade on the back of solid first numbers. Profit rose four-fold and margins came in at a multi-quarter high. The year-on-year (YoY) revenues for the company in the quarter gone by were up 33 percent at Rs 538 crore versus Rs 405 crore.

EBITDA too was up 175 percent at Rs 173 crore versus Rs 62.94 crore. Throwing further light on earnings and outlook going forward, Subhrakant Panda, MD of the company said, the blowout performance is basis steady operating performance and due to sharp increase in ferrochrome prices due to supply-side issues.

“If one were to look at Q1 of last fiscal versus this, then stainless steel production has increased worldwide by 25-26 percent, while ferrochrome supply increased six percent and if one looked quarter on the quarter that is Q4 to Q1 then stainless steel production worldwide increased 3 percent while that of ferrochrome supply reduced by 6.5 percent and that was on account of supply-side constraints. The most prominent being electricity restriction in China, which is largest ferrochrome producer,” said Panda, adding that social unrest in South Africa, which is not only largest producer but also the largest supplier of ferrochrome to China and as a result of all these prices shot up.

The company has guided for an EBITDA of Rs 250-300 crore for the first half of FY22. Panda, said EBITDA depends on the way prices hold up and if they hold the way they are at the moment, then the company would do in excess of Rs 250 crore in Q2 itself but expect sanity to prevail in terms of prices for ferrochrome going forward.

“Even assuming a little bit of cooling off in prices going ahead, still expect, Q2 EBITDA should be around Rs 250 crore or little better than that,” Panda told CNBC-TV18.

On debt, he said, “As much as debt repayment is concerned after the first quarter, we are at Rs 360 crore of long-term debt and scheduled repayment will bring us close to Rs 300 crore of long-term debt at end of current fiscal but given the way situation is, we expect to prepay at least another Rs 40-50 crore if not more.”

F

or the entire interview, watch the video

(Edited by : Abhishek Jha)

First Published:Jul 26, 2021 6:54 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Atlassian Insider Sold Shares Worth $2,115,143, According to a Recent SEC Filing
Atlassian Insider Sold Shares Worth $2,115,143, According to a Recent SEC Filing
Feb 3, 2025
03:24 AM EST, 02/03/2025 (MT Newswires) -- Scott Farquhar, 10% Owner, Director, on January 30, 2025, sold 7,948 Class A common shares in Atlassian ( TEAM ) for $2,115,143. Following the Form 4 filing with the SEC, Farquhar has control over a total of 325,868 shares of the company, with 325,868 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1650372/000156218025000731/xslF345X05/primarydocument.xml ...
Atlassian Insider Sold Shares Worth $2,115,145, According to a Recent SEC Filing
Atlassian Insider Sold Shares Worth $2,115,145, According to a Recent SEC Filing
Feb 3, 2025
03:24 AM EST, 02/03/2025 (MT Newswires) -- Michael Cannon-Brookes, 10% Owner, Director, Chief Executive Officer, Co-Founder, on January 30, 2025, sold 7,948 Class A common shares in Atlassian ( TEAM ) for $2,115,145. Following the Form 4 filing with the SEC, Cannon-Brookes has control over a total of 325,868 shares of the company, with 325,868 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1650372/000156218025000730/xslF345X05/primarydocument.xml...
Abbott Laboratories Insider Sold Shares Worth $3,054,574, According to a Recent SEC Filing
Abbott Laboratories Insider Sold Shares Worth $3,054,574, According to a Recent SEC Filing
Feb 3, 2025
03:21 AM EST, 02/03/2025 (MT Newswires) -- Daniel Gesua Sive Salvadori, Executive Vice President, on January 30, 2025, sold 23,771 common shares in Abbott Laboratories ( ABT ) for $3,054,574. Following the Form 4 filing with the SEC, Salvadori has control over a total of 125,697 shares of the company, with 125,697 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1800/000141588925002584/xslF345X05/form4-02012025_120236.xml ...
Northern Trust Insider Sold Shares Worth $2,936,192, According to a Recent SEC Filing
Northern Trust Insider Sold Shares Worth $2,936,192, According to a Recent SEC Filing
Feb 3, 2025
03:22 AM EST, 02/03/2025 (MT Newswires) -- Peter Cherecwich, Chief Operating Officer, on January 29, 2025, sold 26,132 common shares in Northern Trust ( NTRS ) for $2,936,192. Following the Form 4 filing with the SEC, Cherecwich has control over a total of 62,460 shares of the company, with 26,586 shares held directly and 35,874 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/73124/000007312425000032/xslF345X05/wk-form4_1738365078.xml...
Copyright 2023-2026 - www.financetom.com All Rights Reserved